Logo image of NGMS

NEOGAMES SA (NGMS) Stock Fundamental Analysis

NASDAQ:NGMS - Nasdaq - LU2263803020 - Common Stock - Currency: USD

29.45  +0.02 (+0.07%)

Fundamental Rating

3

Overall NGMS gets a fundamental rating of 3 out of 10. We evaluated NGMS against 131 industry peers in the Hotels, Restaurants & Leisure industry. NGMS has a bad profitability rating. Also its financial health evaluation is rather negative. NGMS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NGMS has reported negative net income.
The reported net income has been mixed in the past 5 years: NGMS reported negative net income in multiple years.
In the past 5 years NGMS always reported a positive cash flow from operatings.
NGMS Yearly Net Income VS EBIT VS OCF VS FCFNGMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.95%, NGMS is doing worse than 75.37% of the companies in the same industry.
NGMS has a Return On Equity (-9.62%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.95%
ROE -9.62%
ROIC N/A
ROA(3y)-1.35%
ROA(5y)-1.84%
ROE(3y)-6.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NGMS Yearly ROA, ROE, ROICNGMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 100 200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NGMS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NGMS Yearly Profit, Operating, Gross MarginsNGMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

More info and screens

3

2. Health

2.1 Basic Checks

NGMS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NGMS has more shares outstanding
Compared to 5 years ago, NGMS has more shares outstanding
Compared to 1 year ago, NGMS has a worse debt to assets ratio.
NGMS Yearly Shares OutstandingNGMS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M
NGMS Yearly Total Debt VS Total AssetsNGMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

NGMS has an Altman-Z score of 2.20. This is not the best score and indicates that NGMS is in the grey zone with still only limited risk for bankruptcy at the moment.
NGMS has a Altman-Z score of 2.20. This is in the better half of the industry: NGMS outperforms 66.42% of its industry peers.
NGMS has a Debt/Equity ratio of 1.61. This is a high value indicating a heavy dependency on external financing.
NGMS's Debt to Equity ratio of 1.61 is in line compared to the rest of the industry. NGMS outperforms 55.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Altman-Z 2.2
ROIC/WACCN/A
WACC8.07%
NGMS Yearly LT Debt VS Equity VS FCFNGMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.10 indicates that NGMS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.10, NGMS is in line with its industry, outperforming 55.22% of the companies in the same industry.
NGMS has a Quick Ratio of 1.10. This is a normal value and indicates that NGMS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NGMS (1.10) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
NGMS Yearly Current Assets VS Current LiabilitesNGMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.14% over the past year.
Looking at the last year, NGMS shows a very strong growth in Revenue. The Revenue has grown by 95.92%.
NGMS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 52.14% yearly.
EPS 1Y (TTM)32.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.08%
Revenue 1Y (TTM)95.92%
Revenue growth 3Y57.31%
Revenue growth 5Y52.14%
Sales Q2Q%-25.46%

3.2 Future

The Earnings Per Share is expected to grow by 60.44% on average over the next years. This is a very strong growth
Based on estimates for the next years, NGMS will show a quite strong growth in Revenue. The Revenue will grow by 13.74% on average per year.
EPS Next Y43.33%
EPS Next 2Y60.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.79%
Revenue Next 2Y13.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
NGMS Yearly Revenue VS EstimatesNGMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
NGMS Yearly EPS VS EstimatesNGMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0 0.2 -0.2 0.4 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NGMS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NGMS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NGMS Price Earnings VS Forward Price EarningsNGMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

NGMS's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. NGMS is more expensive than 77.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.56
NGMS Per share dataNGMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as NGMS's earnings are expected to grow with 60.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.44%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NGMS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEOGAMES SA

NASDAQ:NGMS (4/23/2024, 8:15:31 PM)

29.45

+0.02 (+0.07%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-06 2024-03-06/amc
Earnings (Next)05-08 2024-05-08/amc
Inst Owners0.95%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap990.40M
Analysts48.89
Price Target30.09 (2.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-145.35%
Min EPS beat(2)-268.15%
Max EPS beat(2)-22.55%
EPS beat(4)1
Avg EPS beat(4)-160.08%
Min EPS beat(4)-434.22%
Max EPS beat(4)84.59%
EPS beat(8)1
Avg EPS beat(8)-315.68%
EPS beat(12)3
Avg EPS beat(12)-187.07%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-23.07%
Min Revenue beat(2)-28.81%
Max Revenue beat(2)-17.33%
Revenue beat(4)0
Avg Revenue beat(4)-18.92%
Min Revenue beat(4)-28.81%
Max Revenue beat(4)-9.94%
Revenue beat(8)0
Avg Revenue beat(8)-26.02%
Revenue beat(12)1
Avg Revenue beat(12)-22.8%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.43%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-160.87%
EPS NY rev (3m)-160.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.65
P/FCF N/A
P/OCF N/A
P/B 7.34
P/tB N/A
EV/EBITDA 29.56
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.33
BVpS4.01
TBVpS-5.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.95%
ROE -9.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.35%
ROA(5y)-1.84%
ROE(3y)-6.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Debt/EBITDA 5.44
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 2.2
F-ScoreN/A
WACC8.07%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.08%
EPS Next Y43.33%
EPS Next 2Y60.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)95.92%
Revenue growth 3Y57.31%
Revenue growth 5Y52.14%
Sales Q2Q%-25.46%
Revenue Next Year2.79%
Revenue Next 2Y13.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-192.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year945.51%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y455.87%
FCF growth 3Y77.09%
FCF growth 5YN/A
OCF growth 1Y51.47%
OCF growth 3Y33.31%
OCF growth 5Y60.94%